Vimarsana
Biggest News Aggregation in the World

Page 5 - Alvr News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alvr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alvr Today - Breaking & Trending Today

AlloVir, Inc. (NASDAQ:ALVR) CEO Sells $16,088.75 in Stock - Vimarsana News

AlloVir, Inc. (NASDAQ:ALVR) CEO Sells $16,088.75 in Stock

AlloVir, Inc. (NASDAQ:ALVR – Free Report) CEO Diana Brainard sold 5,275 shares of the company’s stock in a transaction on Wednesday, July 5th. The stock was sold at an average price of $3.05, for a total value of $16,088.75. Following the sale, the chief executive officer now owns 915,641 shares of the company’s stock, valued […]

Insider Buying: AlloVir, Inc. (NASDAQ:ALVR) Major Shareholder Purchases $10,990,762.50 in Stock - Vimarsana News

Insider Buying: AlloVir, Inc. (NASDAQ:ALVR) Major Shareholder Purchases $10,990,762.50 in Stock

AlloVir, Inc. (NASDAQ:ALVR – Free Report) major shareholder Gilead Sciences, Inc. acquired 2,930,870 shares of the stock in a transaction dated Tuesday, June 27th. The stock was acquired at an average cost of $3.75 per share, with a total value of $10,990,762.50. Following the completion of the transaction, the insider now owns 16,635,286 shares in […]

Source: wkrb13.com
Analyzing AlloVir (NASDAQ:ALVR) and Vitro Diagnostics (OTCMKTS:VODG) - Vimarsana News

Analyzing AlloVir (NASDAQ:ALVR) and Vitro Diagnostics (OTCMKTS:VODG)

AlloVir (NASDAQ:ALVR – Free Report) and Vitro Diagnostics (OTCMKTS:VODG – Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, institutional ownership, profitability, dividends and earnings. Earnings and Valuation This table compares AlloVir and Vitro Diagnostics’ top-line […]

AlloVir Shares Drop 28% After $75M Public Offering Prices - Vimarsana News

AlloVir Shares Drop 28% After $75M Public Offering Prices

By Chris Wack AlloVir shares were down 28% to $3.55 after the company said it priced an underwritten public offering of 20 million shares at $3.75 a share....

AlloVir, Inc. (NASDAQ:ALVR) CAO Brett R. Hagen Sells 5,045 Shares - Vimarsana News

AlloVir, Inc. (NASDAQ:ALVR) CAO Brett R. Hagen Sells 5,045 Shares

AlloVir, Inc. (NASDAQ:ALVR – Get Rating) CAO Brett R. Hagen sold 5,045 shares of AlloVir stock in a transaction that occurred on Friday, June 9th. The shares were sold at an average price of $5.64, for a total transaction of $28,453.80. Following the sale, the chief accounting officer now directly owns 129,512 shares in the […]